University of Granada researchers patent new treatment for acne

University of Granada scientists have patented a new treatment for acne that is based on completely natural substances and is much more effective than artificial formulas because it does not create resistance to bacteria and has no secondary effects.

The formula, developed in the Department of Microbiology, is applied directly on the skin. The principle ingredient is a circular, 70 amino acid protein known as AS-48, produced by Enterococcusbacteria and with no proven haemolytic or toxic activity.

As University of Granada Professor and project lead researcher Mercedes Maqueda-Abreu explains, "the human skin is the first physical barrier protecting our bodies from the exterior, but it also has to be considered as a biological barrier housing beneficial microorganisms, the microbiota of the skin, populated by bacteria and different fungus species that stop pathogens from developing." Altering the natural equilibrium of these microorganisms leads to infections that are sometimes difficult to treat—like acne (acne vulgaris), "a very common skin infection, principally in puberty, that causes aesthetic and health problems and damages self-esteem," or other very common skin infections produced byStaphylococcus aureus or Streptococcus pyogenes.

Ineffective treatments

The Propionibacterium acnes bacteria is responsible for this infection when it develops, out of control, in areas abundant in sebaceous secretions. Current treatments are not always effective because resistance develops or undesirable side effects occur. Skin infections caused by S. aureus and S. pyogenes are increasingly demonstrating antibiotic multiresistance. They lead to serious pathologies but, to some extent, are susceptible to topical antibacterial treatment too.

The new formula developed at the University of Granada—and patented through the Office for the Transfer of Research Results (Otri)—"draws on natural substances with antibacterial activity, so they can be used as cosmetic and/or pharmaceutical ingredients in the treatment and prophylaxis of these infections," affirms Prof. Maqueda-Abreu.

The AS-48 protein, on which the patented formula is based, has a broad spectrum of action against Gram-positive bacteria. These include important pathogens such as different species of staphylococcus, streptococcus, clostridia, micobacteriaceae and listeria, among others. Potentially, it could have many applications in human and animal clinical care and as a biopreservative in foods.

"In vitro, topical use of AS-48 alone, or together with agents that enhance its activity, has proved highly efficient in controlling the microorganisms responsible for the skin infections we're talking about", says Prof. Maqueda-Abreu.

The formula patented at the University of Granada, which does not lose activity when stored at different temperatures or on account of interactions between the active molecules and cosmetic compounds has, moreover, a further added advantage: as AS-48 targets the bacteria cell membrane, pathogen resistance is highly unlikely to develop.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers explore gut bacteria's role in fighting breast cancer